This post is a brief outline of my physical “Thyroid Therapy Transformation,” a glimpse into my personal life and how symptoms and body composition changed in response to changes in thyroid therapy and diet. You can see my favorite colors… Read More ›
One of Thyroid Patients Canada’s values is to bring to light little-known aspects of the history of thyroid therapy so that it can open minds about future possibilities. The history of L-T3 (Liothyronine) monotherapy brings to light the flexibility and… Read More ›
How long does it take for the final dose of synthetic LT3 (Liothyronine) hormone to clear from blood, and how much suffering might a withdrawal cause? This is an important question for many people who dose LT3. They want to… Read More ›
Lack of knowledge about Free T3 peaks and valleys contributes to failure and frustration in T3-based therapies, including desiccated thyroid and T3-T4 combination therapy. On patient support groups, I often see conversations that go like this: “My FT3 result was… Read More ›
What does NEW thyroid science have to say on the topic of thyroid pharmaceutical equivalency? How many micrograms of L-T3 Liothyronine (i.e. Cytomel) are equivalent to L-T4 Levothyroxine (i.e. Synthroid)? Thyroid hormone pharmaceutical monographs currently provide very rigid and low-ratio… Read More ›
In thyroid therapy, how many micrograms of Cytomel (T3) are equivalent to how many micrograms of Synthroid (T4)? Pharmaceutical equivalency statements in the product monographs for Pfizer Canada’s Cytomel and for ERFA Canada’s “Thyroid” (desiccated thyroid extract, DTE, or natural… Read More ›
This post continues my paraphrase of Jonklaas et al’s 2014 “Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement.” Posts in this series: 2014 ATA Thyroid therapy guidelines: 1. Levothyroxine 2014… Read More ›
In the “Dirty Money” series on Netflix, the “Drug Short” episode (1) helped me understand some of the economic forces that may have influenced T3 / Liothyronine price hikes in the UK. It makes me concerned about the future of… Read More ›